AWM
RANI icon

Activest Wealth Management’s Rani Therapeutics RANI Stock Holding History

Activest Wealth Management’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,800
Closed -$50.8K – 550
2024
Q1 		$30.5K Hold
9,800
– – 0.01% 148
2023
Q4 		$32.5K Hold
9,800
– – 0.02% 121
2023
Q3 		$21.3K Buy
+9,800
New +$37.4K 0.01% 132

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Activest Wealth Management's RANI Position: Q2 2024 in Review

Activest Wealth Management sold out of Rani Therapeutics (RANI) in Q2 2024, closing a stake of 9,800 shares — an estimated $50.8K sold.

Activest Wealth Management first reported a position in RANI in Q3 2023 and held it in 3 quarters. The position peaked at $32.5K in Q4 2023. 34 funds tracked by Wall St. Rank hold RANI as of Q2 2024.

  • Activest Wealth Management reported no remaining Rani Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Activest Wealth Management sold 9,800 Rani Therapeutics shares in Q2 2024, an estimated $50.8K.
  • Activest Wealth Management first reported a position in Rani Therapeutics in Q3 2023 and held it in 3 quarters.
  • Activest Wealth Management's Rani Therapeutics position peaked at $32.5K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2024.

Based on Activest Wealth Management's 13F filing for Q2 2024, filed 30 Jul 2024.